Although increased blood-brain barrier (BBB) permeabil ity is observed as a result of cerebral ischemia, 1,2 disruption of the BBB has also been identified in other pathological conditions, such as multiple sclerosis. 3 Furthermore, cere brovascular abnormalities have been observed in cognitive disorders. 4 BBB permeability increases with normal aging, and further increases in patients with vascular dementia, 5 suggesting that BBB dysfunction is present from an early stage in patients exhibiting mild symptoms of cognitive impairment and minor cerebral microvascular diseases, such as lacunar stroke.
original contributions ARB on BBB Permeability and Cognitive Impairment angiotensin II (AngII) levels result in impaired cognitive func tion in renin/angiotensinogen transgenic mice. 13 Furthermore, treatment with an angiotensin receptor blocker (ARB) amel iorates the cognitive impairment in mice fed a highsalt and cholesterol diet, or type2 diabetic mice. 14, 15 In addition, ARB treatment decreases BBB permeability in diabetic rats, 16 which suggests that activation of the brain RAS is involved in the pathogenesis of cognitive impairment and BBB permeability in certain pathophysiological conditions. However, Hirawa et al. 17 reported that longterm inhibition of RAS improves memory function in aged, lowsalt treated, normotensive, Dahl saltsen sitive (DSS) rats. However, it has not been determined whether increased BBB permeability induced by inappropriate activa tion of brain RAS contributes to cognitive deficits observed during development of saltdependent hypertension.
Therefore, the present study tested the hypothesis that aug mentation of BBB permeability and cognitive impairment are associated with inappropriate activation of the brain RAS dur ing development of saltdependent hypertension. To test this, BBB permeability was analyzed, as well as TJ expression, cog nitive function, and the effects of an ARB at a subpressor dose, in DSS hypertensive rats.
Methods
Animals. All experimental procedures were performed accord ing to guidelines for the care and use of animals established by the Kagawa University Medical School (Kagawa, Japan). Adult, male, 5weekold, DSS rats (average weight 190 g) were purchased from SeakYoshitomi, Fukuoka, Japan. All animals were housed in a room with controlled lighting and tempera ture (25 °C) . After a 1week adjustment period, the 6week old rats were assigned to three groups: lowsalt diet (DSS/L; 0.3% NaCl; Oriental Yeast, Osaka, Japan, n = 16), highsalt diet (DSS/H; 8% NaCl; Oriental Yeast, n = 16), and highsalt diet treated with the ARB, olmesartan (DaiichiSankyo, Tokyo, Japan, n = 16). The olmesartan dose was 1 mg/kg, once a day, by oral gavage for 4 weeks, which was determined on the basis of previous rat studies. 18, 19 Furthermore, our preliminary experiments showed that 1 mg olmesartan/kg body weight/day did not alter blood pressure in DSS/H rats (data not shown). Systolic blood pressure was monitored in conscious rats using tailcuff plethysmography (BP98A; Softron, Tokyo, Japan) each week. For BBB permeability detection, eight animals per group were anesthetized with pentobarbital sodium (50 mg/ kg, intraperitoneal) and perfused with a fixative solution composed of 2.5% glutaraldehyde and 2% paraformaldehyde.
In the remaining animals, brain tissues were collected follow ing decapitation to measure AngII and gene expression, as well as for immunohistochemical analyses (n = 8 for each).
BBB permeability. As previously described, 12 microvessel per meability was analyzed in the hippocampus and corpus cal losum through the use of horseradish peroxidase. Following perfusion with 2.5% glutaraldehyde/2% paraformaldehyde, the brains were separated and maintained in another fixative solution composed of 1.25% glutaraldehyde/1% paraformal dehyde, for 24 h. For light microscope observation, sections were incubated in 0.01 mol/l acetate buffer (pH 3.3), followed by tetramethylbenzidine and hydrogen peroxide.
Passive avoidance test. To analyze cognitive functions, a shut tle avoidance cage (64 × 35 × 33 cm; Melquest, Toyama, Japan) and an isolation cabinet (72 × 67 × 63 cm; Melquest) were used, as previously described. 20 Briefly, the rats were individually placed in a chamber and administered 20 inescapable, electric shocks (0.4 mA) for 5 s each. A tone signal was presented dur ing the first 5 s of each trial. If there was no avoidance response within that period, the tone signal remained on and the shock was delivered through the grid floor. In the case of a noescape response during this period, both tone and shock were auto matically terminated. Cognitive function was determined by avoidance rate percentage.
Immunohistochemistry. Occludin colocalization with PECAM1positive endothelial cells was assessed in hippoc ampal microvessels. Brain tissue was immersed in optimal cutting temperature compound (TissueTek; Sakura Finetek, Tokyo, Japan) and stored at −80 °C. The tissue was then cut into 10µm thick frozen sections. Following immersion in methanol and phosphatebuffered saline wash steps, the sec tions were blocked with serumfree protein block (Dako Cytomation, Glostrup, Denmark) for 15 min. Subsequently, the primary antibodies were diluted with Canget signal immu nostain (Toyobo, Tokyo, Japan) and incubated overnight at 4 °C. The antibodies included goat polyclonal antimouse platelet endothelial adhesion molecule (PECAM1; 1:200; Santa Cruz Biotechnology, Santa Cruz, CA) and rabbit anti occludin (1:200; Santa Cruz Biotechnology). The sections were then incubated at room temperature for 1 h with fluorescein conjugated secondary antibody in Canget signal immunos tain (Toyobo; 1:800, donkey antigoat and donkey antirabbit; Molecular Probes, Eugene, OR), mounted with Vectashield Gene expression. Occludin, claudin-5, collagen-IV, and metalloproteinase (MMP)2 and 9 were analyzed by lasercapture microdissection in the hippocampus and corpus callosum of frozen brain samples. First, tissue blocks were sectioned at 10µm thickness using a cryostat microtome (Leica CM1950; Leica Microsystems, Tokyo, Japan). The sections were incu bating in increasing concentrations of ethanol, followed by xylene. For RNA isolation from lasercapture microdis section samples, a Micro Scale RNA Isolation Kit was used (RNAqueousMicro; Ambion, Austin, TX). All primers for realtime PCR are shown in Table 1 .
AngII measurements. After brain tissues were quickly removed, part of the cerebral cortex and hippocampus were immediately separated and frozen. For plasma sample col lection, a proteolytic enzyme inhibitor cocktail (EDTA2Na 500 mmol/l; Captopril 10 nmol/l; Pepstatin 1 mmol/l + 1,10 phenanthroline 125 mmol/l) was added to each sample. Brain and plasma AngII were measured using a previously described radioimmunoassay method. 21, 22 Statistical analyses. All values were expressed as mean ± s.d. Differences in blood pressure and passive avoidance test results among groups were determined using repeated measurements of analysis of variance. Differences in AngII protein concentrations and mRNA levels were examined using oneway analysis of variance. When overall analysis of variance P values were <0.01, Bonferroni's correction for multiple comparisons was used to assess individual group differences.
results systolic blood pressure and body weight
Lowsalt diet treatment for 4 weeks did not alter systolic blood pressure in the DSS rats (123 ± 4 mm Hg, Figure 1a) , whereas DSS/H rats exhibited increased systolic blood pressure (176 ± 5 mm Hg) at 4 weeks. Olmesartan did not alter systolic blood pressure in DSS/H rats (174 ± 4 mm Hg) at 4 weeks. Changes in body weight throughout the experimental period were similar between groups (data not shown).
cognitive functions
Figure 1b shows cognitive function as determined by avoid ance rate percentage. DSS/L rats exhibited gradual improve ment in cognitive functions, whereas cognitive functions in the DSS/H rats were significantly decreased. Olmesartan treat ment significantly ameliorated the cognitive deficits in the DSS/H rats.
BBB microvessel leakage
As previously mentioned, BBB permeability was evaluated by measuring percentage leakage of horseradish peroxidase tetramethylbenzidine. 12 DSS/L rats exhibited very little leak age (7 ± 1%) from microvessels in the hippocampus and corpus callosum (Figure 2) . In contrast, substantial leakage took place in the ventral hippocampus and corpus callosum of DSS/H rats (34 ± 3%). Olmesartan markedly reduced BBB microvessels permeability in DSS/H rats (16 ± 7%). (Figures 3 and 4) .
immunohistochemistry
To determine TJ expression, occludin colocalization in PECAM1positive endothelial cells was analyzed in microves sels of the hippocampus and corpus callosum by immunohis tochemistry. PECAM1positive endothelial cells were present in all groups ( Figure 5 ). Occludin expression was observed around microvessels of the hippocampus and corpus callosum in the DSS/L rats. However, very low occludin expression was observed in hippocampal microvessels of the DSS/H rats, but olmesartan treatment significantly restored expression. original contributions
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Plasma and brain angii levels
Plasma AngII levels were decreased in DSS/H rats, compared with DSS/L rats (Figure 6a) . In contrast, DSS/H rats exhibited approximately twofold greater AngII levels in the hippocam pus, compared with DSS/L rats (Figure 6b) . However, cerebral cortical AngII levels were similar between DSS/L and DSS/H rats (data not shown). In the DSS/H rats, olmesartan treatment significantly decreased hippocampal AngII concentrations to levels similar to the DSS/L rats (Figure 6b) . Treatment with olmesartan tended to increase plasma AngII levels, but these changes were not statistically significant (Figure 6a ).
discussion
Smallvessel disease is a major risk factor for vascular dementia, 23, 24 and brain vessel remodeling is a key contribu tor to cerebrovascular dysfunction in several diseases. 25 The present study demonstrated, for the first time, that cognitive impairment is associated with increased hippocampal AngII levels and BBB permeability during hypertension develop ment in DSS/H rats. Furthermore, treatment with the ARB, olmesartan, at a dose that did not alter blood pressure, mark edly restored BBB disruption and reduced cognitive decline in DSS/H hypertensive rats. These data were consistent with the hypothesis that inappropriate activation of the brain RAS contributes to the pathogenesis of BBB injury and cognitive impairment during the development of saltdependent hyper tension. ARB treatment could elicit beneficial effects for cog nitive impairment by protecting against BBB injury in patients with saltdependent hypertension, independently of blood pressure changes.
The present study showed that RAS inhibition with an ARB protected cognitive deficits in DSS/H hypertensive rats in a blood pressureindependent manner. These results were consistent with previous studies showing that longterm treatment with an ARB or angiotensinconverting enzyme inhibitor ameliorated impaired cognitive function in aged, low salttreated, normotensive, DSS rats. 17 Additionally, a series of studies reported disruption of passive avoidance retention by AngII infusion in the central nervous system. 26, 27 Interestingly, AngII administration to the hippocampal area resulted in induction of longterm potentiation in the hip pocampus. 28 The present study showed that cognitive impair ment was associated with increased hippocampal AngII levels in DSS/H hypertensive rats. These data were consistent with the hypothesis that augmentation of brain RAS activity contributes to the progression of cognitive decline. [13] [14] [15] [16] [17] 28 It should be noted that AngII levels were measured using the direct radioimmunoassay method, 21, 22 without separation of Ang peptides by highperformance liquid chromatography. Therefore, AngII values should represent actual concentra tions of AngII + AngIII.
The present study also demonstrated that cognitive deficits were associated with augmented BBB permeability in the DSS rats. The BBB neurovascular unit acts as an obstacle for sub stance delivery to the central nervous system. In particular, under physiological conditions, TJs and collagenIV are key components in the regulation of BBB function. 2 Impaired BBB function has been shown to contribute to the pathophysiol ogy of several brain diseases, including cognitive disorders. 29 In the present study, cognitive deficits and increased BBB per meability were accompanied by reduced expression of TJs and collagen-IV and increased MMP-9 gene expression in the hip pocampus and corpus callosum of DSS/H hypertensive rats. Furthermore, ARB treatment attenuated BBB injury and the reduction in TJ and collagen-IV expression in the DSS/H rats. Collectively, these results were consistent with the hypoth esis that AngIIinduced reductions in neurovascular unit components of the BBB, such as TJs and collagenIV, con tribute to altered BBB permeability and associated cognitive impairments.
Although the precise mechanisms responsible for the delete rious effect of AngII on BBB injury are not clear, one possible mechanism is that AngII stimulates the production of proin flammatory cytokines and activates MMPs, which further medi ate TJ disruption and BBB permeability and ultimately lead to cognitive dysfunction. [30] [31] [32] In aged, lowsalttreated, normoten sive, DSS rats, improved cognitive function mediated by RAS inhibitors was associated with preservation of neuronal capil lary densities in the hippocampal area. 17 Therefore, it is possible that some of the neuroprotective effects of ARBs on BBB per meability are accompanied by restoration of TJ and collagenIV expression in the BBB. In the present study, MMP9 expression was significantly increased in hippocampal tissues of DSS/H rats. Although in situ zymography was not performed to meas ure MMP activity due to the small amount of tissue, these results suggest a potential role for MMP9 in BBB injury in DSS rats. original contributions
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Olmesartan treatment also resulted in significantly decreased hippocampal MMP9 expression in the DSS/H rats. Previous studies have shown that cognitive deficits and BBB permeabil ity are associated with increased oxidative stress. 13, 33 Therefore, it can be speculated that ARB effects on MMP9 expression are mediated by their antioxidative stress effects. However, further studies are needed to address these issues. The present study showed that a highsalt diet inappropri ately increased AngII contents in the hippocampus of DSS rats, whereas plasma AngII levels were significantly decreased. These results were consistent with previous studies showing that a highsalt diet increased AngII levels and AT1 receptor density in tissues. 34, 35 Systemic olmesartan treatment decreased AngII levels in hippocampal tissues of DSS/H rats, suggesting that at least some neuroprotective effects of ARB could be explained by reduced brain AngII levels. However, the precise mechanisms responsible for high saltinduced activation of the brain RAS, as well as effects of olmesartan on brain AngII levels, remain poorly understood. Nevertheless, we recently demonstrated that systemic treatment for 2 weeks with the ARB candesartan decreases brain AngII levels, as well as angiotensinconverting enzyme and angiotensinogen gene expression, in AngIIinfused hypertensive rats, although candesartan concentrations in brain tissues were below detectable limits. 36 In contrast, other ARBs, such as losartan, partially penetrate the BBB and selectively inhibit central AT1 receptors. 37 These results suggest that ARBs penetrate the BBB at very low concentrations, but these levels could be sufficient to regulate the brain RAS.
In conclusion, the present study supported the hypothesis that RAS activation in the hippocampus plays a key role in the pathogenesis of reduced neurovascular TJs and BBB disrup tion, which leads to cognitive deficits in DSS hypertensive rats. Furthermore, in the DSS/H hypertensive rats, RAS inhibition attenuated these changes without altering blood pressure. These data supported the recently introduced clinical concept that the neurovascular unit is an important therapeutic tar get for brain protection. 38 However, the precise mechanisms underlying the neurovascular protective effects of RAS inhibi tors, as well as the pathophysiological relevance in prevent ing cognitive decline, need to be further investigated to better understand the role of local RAS in the pathogenesis of cogni tive disorders. Furthermore, DSS rats do not emulate exactly the pathophysiology of saltsensitive hypertensive patients. Therefore, future clinical studies will be needed.
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